| Literature DB >> 28877672 |
Irmak Baran1,2, Arife Polat Düzgün3, İpek Mumcuoğlu4, Neriman Aksu4.
Abstract
BACKGROUND: Kerstersia gyiorum is an extremely rare pathogen of human infection. It can cause chronic infection in patients with underlying conditions. It can easily be misdiagnosed if proper diagnostic methods are not used. CASEEntities:
Keywords: 16S rRNA gene sequencing; Buerger’s Disease; Chronic wound infection; Kerstersia gyiorum; MALDI-TOF MS; Thromboangiitis obliterans
Mesh:
Substances:
Year: 2017 PMID: 28877672 PMCID: PMC5588736 DOI: 10.1186/s12879-017-2711-3
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Appearance of wound on the foot
Fig. 2Appearance of wound on ankle
Fig. 3Kerstersia gyiorum on blood agar
Fig. 4Gram stain from the pure culture of Kerstersia gyiorum. Gram-negative, short rods were seen
Antimicrobial susceptibility profile of Kerstersia gyiorum as determined by Phoenix 100 and E-test
| Phoenix 100 | E-test | |||
|---|---|---|---|---|
| Antimicrobial agent | MIC (μg/mL) | Result | MIC (μg/mL) | Result |
| Amikacin | ≤4 | Susceptible | – | – |
| Aztreonam | ≤1 | Susceptible | – | – |
| Ceftazidime | ≤0.5 | Susceptible | – | – |
| Ceftriaxone | – | – | 0.25 | Susceptible |
| Ciprofloxacin | ≤0.125 | Susceptible | 0.25 | Susceptible |
| Colistin | >4 | Resistant | >256 | Resistant |
| Gentamicin | 2 | Susceptible | 1 | Susceptible |
| Imipenem | – | – | 2 | Susceptible |
| Meropenem | ≤0.125 | Susceptible | – | – |
| Netilmicin | 2 | Susceptible | – | – |
| Piperacillin | ≤4 | Susceptible | – | – |
| Piperacillin-tazobactam | ≤4/4 | Susceptible | – | – |
| Trimethoprim-sulfamethoxazole | ≤1/19 | Susceptible | ≤2/38 | Susceptible |
Antimicrobial susceptibility results of Proteus vulgaris, Enterobacter cloacae, Morganella morganii
|
|
|
| |
|---|---|---|---|
| Amikacin | Susceptible | Susceptible | Susceptible |
| Amoxicillin-clavulanic acid | Susceptible | Resistant | Resistant |
| Ampicillin | Resistant | Resistant | Resistant |
| Ampicillin-sulbactam | Susceptible | Susceptible | Susceptible |
| Ertapenem | Susceptible | Susceptible | Susceptible |
| Gentamicin | Susceptible | Susceptible | Susceptible |
| Imipenem | Intermediate | Susceptible | Susceptible |
| Levofloxacin | Susceptible | Susceptible | Susceptible |
| Meropenem | Susceptible | Susceptible | Susceptible |
| Piperacillin-tazobactam | Susceptible | Susceptible | Susceptible |
| Cefepime | Susceptible | Susceptible | Susceptible |
| Cefoxitin | Susceptible | Susceptible | Susceptible |
| Cefotaxime | Susceptible | Susceptible | Susceptible |
| Ceftriaxone | Resistant | Susceptible | Susceptible |
| Cefuroxime | Susceptible | Susceptible | Susceptible |
| Ciprofloxacin | Susceptible | Susceptible | Susceptible |
| Tobramycin | Susceptible | Susceptible | Susceptible |
| Trimethoprim-sulfamethoxazole | Resistant | Resistant | Susceptible |
Fig. 5Appearance of the patient’s foot at the three-month follow-up
Fig. 6A timeline of all events since patient’s first hospitalization
Clinical features of reported cases of Kerstersia spp. after first identification in 2003 by Coenye et al. [1] (Source: PubMed, Medline)
| Year of publication | Reference number | Authors | Patient age | Gender | Smoking history | Clinical condition | Source | Polymicrobial/monomicrobial | Isolated Species | Antibiotic treatment | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012 | 4 | Almuzara et al. | 16 | Male | Absent | Complicated chronic otitis media | Bezold’s abscess | Monomicrobial |
| Iv ampicillin-sulbactam and ceftriaxone (3 days) Oral ciprofloxacin and amoxicillin-clavulanic acid | Recovered |
| 2013 | 2 | Pence et al. | 55 | Male | Present | Chronic otitis medi | Mastoid cavity specimen | Polymicrobial |
| Trimethoprim-sulfamethoxazole (14 days) | Recovered |
| 2013 | 2 | Pence et al. | 61 | Female | Absent | Lower leg ulcer | Wound specimen swab | Polymicrobial |
| Ciprofloxacin (10 days) | Unknown |
| 2014 | 8 | Deutscher et al. | 63 | Female | Absent- | Ventilator-dependent chronic respiratory failure, | Bronchoalveolar lavage | Polymicrobial |
| Piperacillin-tazobactam, doripenem, ciprofloxacin, ceftazidime, colistin | Died from complications |
| 2014 | 6 | Mwalutende et al. | 53 | Male | Present | Chronic suppurative otitis media | Ear swab | Polymicrobial |
| Ciprofloxacin ear drops | Recovered |
| 2014 | 6 | Mwalutende et al. | 33 | Male | Absent | Chronic suppurative otitis media | Ear swab | Polymicrobial |
| Ciprofloxacin ear drops | Recovered |
| 2015 | 5 | Uysal et al. | 25 | Male | Absent | Chronic suppurative otitis media | Ear swab | Polymicrobial |
| Imipenem (10 days) | Recovered |
| 2015 | 7 | Bostwick et al. | 69 | Female | Absent | Chronic lower extremity ulcer, bacteremia, sepsis | Blood culture | Monomicrobial |
| Ciprofloxacin, clindamycin (14 days) | Recovered |
| 2016 | 3 | Ogawa et al. | 82 | Male | Absent | Urinary tract infection | Urine | Polymicrobial |
| Levofloxacin (5 days) | Recovered |
| 2012 | 12 | Vandamme et al. | 54 | Male | Unknown | Unknown | Neck abscess | Unknown |
| Unknown | Unknown |